Market Place
Sourcing Support
Centocor`s Biologic Stelara (ustekinumab) Receives Approval in the U.S.
18 Mar 2024 //
FDA
Centocor`s Biologic Simponi (golimumab) Receives Approval in the U.S.
16 Nov 2023 //
FDA
Centocor`s Biologic Simponi (Golimumab) Receives Approval in the U.S.
30 Mar 2023 //
FDA
Centocor `s Remicade Receives Supplimental Approval in U.S
07 Oct 2021 //
FDA
Centocor`s Remicade (Infliximab) Receives Supplemental Approval in US
18 May 2020 //
FDA
Centocor`s STELARA (ustekinumab) Receives Supplemental Approval
09 Nov 2019 //
FDA
Centocor`s Reopro (Abciximab) Receives Supplemental Approval in US
09 Aug 2019 //
FDA
Janssen Biotech Tremfya (Guselkumab ) Receives Supplemental Approval In US
06 Apr 2019 //
FDA
Trinity Partners Announces Findings from FDA-Approved Drug Performance Index
17 Dec 2018 //
BUSINESSWIRE
Enforcement Report - Week of November 14, 2018
14 Nov 2018 //
FDA
Centocor`s Selara (Ustekinumab) Receives Supplemental Approval In US
22 Feb 2018 //
FDA
Centocor’s Generic Infliximab Receives Supplemental Approval In US
26 Oct 2017 //
FDA
Janssen’s Darzalex Daratumumab Receives Supplemental Approval In US
19 Jun 2017 //
FDA
US FDA approves Darzalex in combo with pomalidomide & dexamethasone for patients
19 Jun 2017 //
PHARMABIZ
Pulmatrix Licenses Novel Drug Candidates from RespiVert subsidiary of Janssen
13 Jun 2017 //
PR NEWSWIRE
Remicade® ( Infliximab): Janssen Biotech V. Celltrion Healthcare & Hospira
31 May 2017 //
PATENT LITIGATION
Remicade® (Infliximab): Janssen Biotech, Inc. V. Samsung Bioepis Co., Ltd.
17 May 2017 //
PATENT LITIGATION
USPTO Files Response Brief in In re Janssen Biotech, Inc. & New York University
15 May 2017 //
PRESS RELEASE
J&J, Celltrion Remicade Biosimilar Dispute Could Settle, Analyst Says
08 Mar 2017 //
BNA
Ionis Pharma receives $5M milestone payment from Janssen under GI collaboration
28 Dec 2016 //
PHARMABIZ
Janssen Submits Two Applications To FDA Seeking Approval Of Simponi aria
20 Dec 2016 //
PR NEWSWIRE
J&J Appeals Remicade Patent Ruling as Pfizer Readies Biosimilar
02 Nov 2016 //
BLOOMBERG
TESARO Announces Acceptance for Review of Niraparib Application by EMA
27 Oct 2016 //
GLOBENEWSWIRE
FDA grants priority review for Genmabs’ daratumumab
12 Oct 2016 //
EUROPEAN PHARMACEUTICAL
U.S. FDA Grants Priority Review for Daratumumab in Relapsed Multiple Myeloma
07 Oct 2016 //
GLOBENEWEWIRE
Janssen Biotech BLA Stelara Approved In US
23 Sep 2016 //
FDA
Janssen seeks to expand use of multiple myeloma drug
20 Aug 2016 //
PHARMATIMES
Bristol-Myers` Opdivo front-and-center in yet another cancer-fighting team-up
27 Jul 2016 //
FIERCE PHARMA
Janssen Announces Clinical Collaboration with Bristol-Myers Squibb
26 Jul 2016 //
PR NEWSWIRE
The Newly Launched IL-17 Inhibitor Cosentyx is Gradually Gaining Momentum in EU5
01 Jun 2016 //
PR NEWSWIRE
Janssen’s Stelara impresses in Crohn’s maintenance trial
25 May 2016 //
PHARMATIMES
SGLT2 Inhibitors - Risk of Diabetic Ketoacidosis
16 May 2016 //
HEALTH CANADA
MorphoSys takes Genmab, J&J to court over CD38 antibody patent
07 Apr 2016 //
FIERCE BIOTECH
J&J grabs prostate cancer rights for Tesaro`s niraparib in $500M deal
07 Apr 2016 //
FIERCE BIOTECH
FDA Approves IMBRUVICA for First-line Treatment of Chronic Lymphocytic Leukemia
05 Mar 2016 //
PR NEWS WIRE
UbiVac Opts to Stay in Portland, Oregon, Expands Lab Space By Factor of 10
18 Feb 2016 //
BIOSPACE
Empliciti on track for European approval in multiple myeloma
03 Feb 2016 //
PM LIVE
Janssen starts phase 2/3 trial of imetelstat in myelodysplastic syndromes
14 Jan 2016 //
PBR
GSK/Janssen RA drug on track for filing next year
17 Dec 2015 //
PHARMATIMES
First Data Unveiled from CALLISTO Program Examining the Use of XARELTO®
07 Dec 2015 //
PR NEWS WIRE
IMBRUVICA Ph2 RESONATE17 Data Show Robust Clinical Activity & Promising Outcomes
07 Dec 2015 //
PR NEWS WIRE
Real-World Data Confirms Safety and Efficacy Profile of XARELTO®
07 Dec 2015 //
PR NEWS WIRE
Janssen`s STELARA® in US and the EU for the treatment of Crohn`s disease
01 Dec 2015 //
PR NEWS WIRE
Janssen`s Darzalex (Daratumumab) approved in US for Multiple myeloma
19 Nov 2015 //
FDA
FDA approves Darzalex for patients with previously treated multiple myeloma
17 Nov 2015 //
FDA
AbbVie Submits IMBRUVICA® (ibrutinib) Phase III Combination Data to U.S. FDA
14 Nov 2015 //
PR NEWS WIRE
Halozyme Announce Clinical Dosing Of Janssen`s Daratumuma by ENHANZE Technology
04 Nov 2015 //
PR NEWS WIRE
UbiVac Announces Collaboration with Johnson & Johnson…
29 Sep 2015 //
PR NEWS WIRE
J&J signs up to assess Nextera`s tech platform in rheumatoid arthritis
24 Sep 2015 //
FIERCE BIOTECH
Berkeley’s Aduro Biotech Isn’t Just on the Mark
21 Sep 2015 //
BIOSPACE
Anvisa suspends drugs manufactured by Janssen- Cilag Ltd. company
29 May 2015 //
ANVISA
Janssen`s Invega Trinza (3- Month Paliperidone Palmitate) Approved in US For Schizophrenia
20 May 2015 //
JANSSEN
